UTMB study: Ozempic raises complication, readmission risk in total shoulder arthroplasty


Ozempic raises complication, readmission risk in total shoulder arthroplasty: Study

Becker’s Orthopedic Review, Dec. 12, 2024

Becker’s highlighted a UTMB study that finds that patients using GLP-1s may face higher risks of complications and readmissions following total shoulder arthroplasty.

Categories